USSTOCK.TODAY
Weekend. Closed Log in Sign up

Windward Bio Group AG(WWB) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

WWB
WWB
New
Windward Bio Group AG
At close Nov 20 at 4:00 PM ET (Korea 11/21 06:00)
$24.28
+0.27 ▲ +1.15%
Nov 20 at 4:00 PM ET (Korea 11/21 06:00)
$24.29
+0.00 +0.00%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -7.42Insider Own ⓘ -Shs Outstand ⓘ 15.4MPerf Week ⓘ -14.79%
Market Cap ⓘ 1.33BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ -Perf Month ⓘ -
Enterprise Value ⓘ 1.14BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 8.95%Short Float ⓘ -Perf Quarter ⓘ -
Income ⓘ -0.07BP/S ⓘ -EPS this Y ⓘ -Inst Trans ⓘ -Short Ratio ⓘ -Perf Half Y ⓘ -
Sales ⓘ 0.00BP/B ⓘ 1.41EPS next 5Y ⓘ -ROA ⓘ -Short Interest ⓘ -Perf YTD ⓘ 32.34%
Book/sh ⓘ 17.21P/C ⓘ 7.13EPS past 3/5Y ⓘ -ROE ⓘ -52W High ⓘ -28.54% ($33.99)Perf Year ⓘ -
Cash/sh ⓘ 3.41P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -25.65%52W Low ⓘ 32.34% ($18.35)Perf 3Y ⓘ -
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -Gross Margin ⓘ -Volatility(W/M) ⓘ 31.74% -Perf 5Y ⓘ -
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -ATR (14) ⓘ 8.4Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 8.57EPS Q/Q ⓘ -31%Profit Margin ⓘ -RSI (14) ⓘ -Recom ⓘ -
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 8.57Sales Q/Q ⓘ -SMA20 ⓘ -6.14% ($25.87)Beta ⓘ -Target Price ⓘ -
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ -SMA50 ⓘ -6.14% ($25.87)Rel Volume ⓘ 0.32Prev Close ⓘ $24.01
Employees ⓘ -LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ -6.14% ($25.87)Avg Volume(3M) ⓘ 0.49MPrice ⓘ $24.28
IPO ⓘ 2026/11/13Option/Short ⓘ No/YesTrades ⓘ 1628Volume ⓘ 158,632Change ⓘ 1.15%
Company
WWB WWBWindward Bio Group AG | NASD | Biotechnology

🫁 A Switzerland-based clinical-stage biotechnology company. It develops long-acting antibody drugs designed to significantly extend dosing intervals, targeting respiratory inflammatory diseases such as asthma and chronic obstructive pulmonary disease (COPD). A single antibody that blocks inflammatory signaling molecules is in Phase 2 clinical trials, and a bispecific antibody that blocks two inflammatory pathways simultaneously is in early-stage clinical trials. There are currently no approved products or revenue.

Quote

Over the past 1 year, roughly in the middle

29% below its 1-year high.

Now $24.28
52w low$18.3552w high$33.99
52W Range38%
Volume ⓘ 158,632

Traded less than usual. That is 32% of its average volume.

C
Overall · average, with some caution
We judged 3 of the 8 questions below. 1 need caution.
No data for growth, valuation, earnings, outlook, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #128 of 598 in the industry

Based on market cap of $1B.

FAQ

FAQ

WWB belongs to the Healthcare sector and operates in the Biotechnology industry.

The market cap of WWB is approximately $1.3B, ranking 2,290 within its sector.

WWB has recorded a 52-week high of $33.99 and a low of $18.35.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels